MCA logo
MCA logo

PUBLIC PORTAL

MEDICALLY REVIEWED

FDA Approves Ublituximab for Relapsing Forms of Multiple Sclerosis

Multiple Sclerosis
In Dec 2022, the FDA approved BRIUMVI™, a chimeric monoclonal antibody (mAb) labelled for the treatment of RMS

Sign Up or Log In as a healthcare professional to read the full article.

Share via

Also worth reading

People also read: